All Stories

  1. A study of the role of androgen receptor and androgen receptor variant 7 in TNBC patients and the effect of their targeting by Enzalutamide and EPI-001 in MDA-MB-231
  2. Rebound increase in microRNA levels at the end of 5-FU-based therapy in colorectal cancer patients
  3. A Study to Explore the Role of IDH1 (R132) Mutation on Imatinib Toxicity and Effect of ABCG2/OCT1 Expression on N-Desmethyl Imatinib Plasma Level in Egyptian Chronic Myeloid Leukemia Patients
  4. Enhanced cytotoxic effect of doxorubicin conjugated gold nanoparticles on breast cancer model
  5. Molecular Design, Spectroscopic, DFT, Pharmacological, and Molecular Docking Studies of Novel Ruthenium(III)–Schiff Base Complex: An Inhibitor of Progression in HepG2 Cells
  6. A Critical Review of Chloroquine and Hydroxychloroquine as Potential Adjuvant Agents for Treating People with Cancer
  7. Determination of the Cut-off Value for Imatinib Plasma Levels Linked to Occurrence of Bone Pain in CML Patients
  8. Laser Enhanced Combinatorial Chemo-photothermal Therapy of Green Synthesis Gold Nanoparticles Loaded with 6Mercaptopurine on Breast Cancer Model
  9. Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations
  10. Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters
  11. Pharmacokinetics and Pharmacodynamics of Dexmedetomidine Administered as an Adjunct to Bupivacaine for Transversus Abdominis Plane Block in Patients Undergoing Lower Abdominal Cancer Surgery
  12. Blockade of CDK7 Reverses Endocrine Therapy Resistance in Breast Cancer
  13. <p>Analgesic Effect of Morphine Added to Bupivacaine in Serratus Anterior Plane Block Following Modified Radical Mastectomy. Only a Local Effect? Randomized Clinical Trial</p>
  14. Suppression of macrophages- Induced inflammation via targeting RAS and PAR-4 signaling in breast cancer cell lines
  15. Simvastatin Evokes An Unpredicted Antagonism For Tamoxifen In MCF-7 Breast Cancer Cells
  16. Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3
  17. Evaluation of tamoxifen and simvastatin as the combination therapy for the treatment of hormonal dependent breast cancer cells
  18. Impact of Global DNA Methylation in Treatment Outcome of Colorectal Cancer Patients
  19. Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes
  20. Improved chemo-photothermal therapy of hepatocellular carcinoma using chitosan-coated gold nanoparticles
  21. Sodium selenite ameliorates both intestinal and extra-intestinal changes in acetic acid-induced colitis in rats
  22. Corrigendum: From Resistance to Sensitivity: Insights and Implications of Biphasic Modulation of Autophagy by Sunitinib
  23. Part III: Novel checkpoint kinase 2 (Chk2) inhibitors; design, synthesis and biological evaluation of pyrimidine-benzimidazole conjugates
  24. Melilotus indicus extract induces apoptosis in hepatocellular carcinoma cells via a mechanism involving mitochondria-mediated pathways
  25. Anticancer potentiality of lignan rich fraction of six Flaxseed cultivars
  26. Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors
  27. From Resistance to Sensitivity: Insights and Implications of Biphasic Modulation of Autophagy by Sunitinib
  28. Anticancer Activities of New N-hetaryl-2-cyanoacetamide Derivatives Incorporating 4,5,6,7-Tetrahydrobenzo[b]thiophene Moiety
  29. Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs
  30. Carbonic anhydrase inhibition boosts the antitumor effects of Imatinib mesylate via potentiating the antiangiogenic and antimetastatic machineries
  31. Design, Synthesis, and Cytotoxicity Evaluation of Novel Griseofulvin Analogues with Improved Water Solubility
  32. Could Caffeic Acid Phenethyl Ester Expand the Antitumor Effect of Tamoxifen in Breast Carcinoma?
  33. Combination of metformin and 5-aminosalicylic acid cooperates to decrease proliferation and induce apoptosis in colorectal cancer cell lines
  34. Modulation of Tamoxifen Cytotoxicity by Caffeic Acid Phenethyl Ester in MCF-7 Breast Cancer Cells
  35. Leptin influences estrogen metabolism and increases DNA adduct formation in breast cancer cells
  36. The Combination ofα-Tocopheryl Succinate and Sodium Selenite on Breast Cancer: A Merit or a Demerit?
  37. A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients
  38. Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines
  39. Dorzolamide synergizes the antitumor activity of mitomycin C against Ehrlich’s carcinoma grown in mice: role of thioredoxin-interacting protein
  40. Cu (I) catalyzed alkyne-azide 1,3-dipolar cycloaddition (CuAAC): Synthesis of 17α-[1-(substituted phenyl)-1,2,3-triazol-4-yl]-19-nor-testosterone-17β-yl acetates targeting progestational and antipro-liferative activities
  41. A study to explore the correlation of trough level concentration and ABCB1, OCT1, ABCG2 genetic polymorphisms with imatinib mesylate induced thrombocytopenia in chronic myeloid leukemia patients.
  42. Combination of imatinib and clotrimazole enhances cell growth inhibition in T47D breast cancer cells
  43. Chemopreventive and therapeutic potentials of thymoquinone in HepG2 cells: mechanistic perspectives
  44. Cytotoxic and Antimicrobial Evaluations of Novel Apoptotic and Anti-Angiogenic Spiro Cyclic 2-Oxindole Derivatives of 2-Amino-tetrahydroquinolin-5-one
  45. Effect of N-acetylcysteine on γ-radiation-induced cytotoxicity in human hepatocellular carcinoma cells
  46. Modulation of Imatinib Cytotoxicity by Selenite in HCT116 Colorectal Cancer Cells
  47. Chloroquine synergizes sunitinib cytotoxicity via modulating autophagic, apoptotic and angiogenic machineries
  48. Modulatory effects of l-carnitine on tamoxifen toxicity and oncolytic activity
  49. Resveratrol inhibits proliferation, angiogenesis and induces apoptosis in colon cancer cells
  50. Synthesis and Biological Evaluation of a Novel Series of Chalcones Incorporated Pyrazole Moiety as Anticancer and Antimicrobial Agents
  51. Pharmacokinetics, immunogenicity and anticancer efficiency of Aspergillus flavipes l-methioninase
  52. Effect of Tumour Necrosis Factor-Alpha on Estrogen Metabolic Pathways in Breast Cancer Cells
  53. Ameliorating effect of DL-α-lipoic acid against cisplatin-induced nephrotoxicity and cardiotoxicity in experimental animals
  54. Promising antitumor effect of alpha-tocopheryl succinate in human colon and liver cancer cells
  55. Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase
  56. Modulation of radiation-induced organs toxicity by cremophor-el in experimental animals
  57. PROPIONYL- ? -CARNITINE AS POTENTIAL PROTECTIVE AGENT AGAINST ADRIAMYCIN-INDUCED IMPAIRMENT OF FATTY ACID BETA-OXIDATION IN ISOLATED HEART MITOCHONDRIA
  58. REVERSAL OF DOXORUBICIN-INDUCED CARDIAC METABOLIC DAMAGE BYL-CARNITINE
  59. Effect of Glutathione Modulation On the Distribution and Transplacental Uptake of 2-[14C]-Chloroacetonitrile (Can) Quantitative Whole-Body Autoradiographic Study in Pregnant Mice
  60. A STUDY ON THE REPRODUCTIVE TOXICITY OF ERYTHROSINE IN MALE MICE
  61. Urinary CA 19.9 as marker for bladder cancer
  62. Effect of glutathione modulation on molecular interaction of [14C]-chloroacetonitrile with maternal and fetal DNA in mice
  63. Pulmonary toxicity of acrylonitrile: covalent interaction and effect on replicative and unscheduled DNA synthesis in the lung